In a press release MGC Pharmaceuticals said it had has secured commitments to raise $4.75 million from ‘sophisticated and professional investors’ at an issue price of 4 cents a share.
The ‘seed to pharmacy’ business will also undertake an offer of shares to existing shareholders to raise up to an additional $1 million at the same issue price.
If successful, this will mean a dual listing for MGC, which is already trading on its home Australian turf; it has engaged Canaccord Genuity in Australia to act as its equity-capital markets’ advisor.
The company’s co-founder and managing director Roby Zomer said the level of interest shown in MGC is a ‘testament to the opportunity that our businesses offers investors in providing exposure to the fast growing medicinal cannabis market and our unique seed to pharmacy strategy’.
MGC Pharmaceuticals has been busy of late and recently announced the signing of a memorandum of understanding with the Maltese government which to create an 11 million Euro medical cannabis manufacturing plant in the Mediterranean island country.
Financial news website Stockhead reports that the cash raised will be used for a number of purposes ‘including ongoing production and sales of its pharmaceutical medicinal cannabis products and construction works at its Maltese manufacturing facility, in what is proving to be a very prosperous period for the company’.
Israel’s Kanabo Research recently revealed it was planning to launch on the London Stock Exchange in the next few weeks, too. Meanwhile London-listed oil and gas explorer, turned CBD company Highlands Natural Resources says it will now concentrate solely on the latter.
In its latest market release its announced that chairman and chief executive Robert Price is leaving the company to pursue other interests. It goes on to say that it aims to conduct an orderly sale or closure of its natural resources businesses and become a ‘vertically-integrated CBD company’.
This transition will be overseen by new chief executive by Nick Tulloch, who joined the company earlier this year as finance director. Highlands is listed on the AIM market, a subsidiary of the London Stock Exchange.
As cannabis laws continue to change at bewildering speeds, the topic of employee workplace protections becomes increasingly relevant. Honestly, with how many people support legalization these days and the astronomical inflation we’ve been experiencing, it makes no sense that cannabis users should have to struggle to find decent jobs. Some states are taking action by […]
The post 7 States Where Cannabis Users Can Easily Find Jobs appeared first on Cannadelics.
The island nation of New Zealand has relied on exports to treat medical cannabis patients so far. Allowing the dispensation of domestically cultivated cannabis will help the nascent industry grow and lower overall costs. Last week, New Zealand officials approved the beginning of the domestically sourced medical cannabis market. The Department of Health began allowing […]
A link to your site, with your site's name and description as anchor text.
Inventory Clearance Sale
Save 60% Off all remaining inventory with Promo Code: ICE